GSK Consumer Healthcare net up 14.6% at Rs 197 cr

Fast-moving consumer goods firm GlaxoSmithKline (GSK) Consumer Healthcare Ltd on Friday reported a 14.6  per cent increase in net profit at Rs 197 crore for the fourth quarter ended March, 2015.

The company had reported a net profit of Rs 172 crore in the same quarter a year ago.

Net sales went up by eight per cent to Rs 1,165 crore in the quarter against Rs 1,079 crore in the corresponding period last year, the company said in a BSE filing.

The company said its quarterly performance was driven by market penetration, greater access to products, and cost efficiency.

Managing Director Zubair Ahmed said, "Our robust financial performance comes on the back of our relentless focus on products that are differentiated by high science and innovation and are propelled through our robust distribution in urban and rural markets."

In a separate filing, the company said its board recommended a dividend at the rate of Rs 55 per share of Rs 10 each.

Shares of GSK Consumer Healthcare closed at Rs 6,371 apiece, down 0.3 per cent from their previous close on the BSE.